Evidence map›Paper›PMID 29355842›Full record

ArticleThe Journal of clinical investigation2018

Aberrant TGF-β activation in bone tendon insertion induces enthesopathy-like disease.

Xiao Wang, Liang Xie, Janet Crane, Gehua Zhen, Fengfeng Li, Ping Yang, Manman Gao, Ruoxian Deng, Yiguo Wang, Xiaohua Jia and 3 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Macrophage Derived TGF-β Recruits BMSCs for Initiation of Bone Formation During Fracture Healing.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. A role for TGFβ signaling in Gli1+ tendon and enthesis cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  8. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  9. Article
  10. Article
  11. The bone marrow side of axial spondyloarthritis.Nature reviews. Rheumatology · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Inhibition of Integrin αvβ6 Activation of TGF-β Attenuates Tendinopathy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Xiao WangDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Liang XieDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Janet CraneDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Gehua ZhenDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Fengfeng LiDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Ping YangDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Manman GaoDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Ruoxian DengDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Yiguo WangDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Xiaohua JiaDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Cunyi FanDepartment of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai, China.
Mei WanDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Xu CaoDepartment of Orthopedic Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Johns Hopkins University · USShanghai Sixth People's Hospital · CNShihezi University · CN

Funding

Trap+ Mononuclear Cells in Periosteal Bone FormationR01AR071432 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CAO, XU · 2017 to 2021
$2.2M
TGF-beta Activity in the Subchondral Bone and Onset of OAR01AR063943 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CAO, XU · 2013 to 2017
$2.2M
Pathogenesis of EnthesopathyR01AR072730 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CAO, XU, WAN, MEI · 2018 to 2022
$1.8M
Temporal-spatial Regulation of MSCs by IGF-1K08AR064833 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CRANE, JANET · 2014 to 2018
$650k
NIAMS NIH HHS K08 AR064833NIAMS NIH HHS R01 AR063943NIAMS NIH HHS R01 AR071432NIAMS NIH HHS R01 AR072730
6 · The paper itself

Abstract

Enthesopathy is a disorder of bone, tendon, or ligament insertion. It represents one-fourth of all tendon-ligament diseases and is one of the most difficult tendon-ligament disorders to treat. Despite its high prevalence, the exact pathogenesis of this condition remains unknown. Here, we show that TGF-β was activated in both a semi-Achilles tendon transection (SMTS) mouse model and in a dorsiflexion immobilization (DI) mouse model of enthesopathy. High concentrations of active TGF-β recruited mesenchymal stromal stem cells (MSCs) and led to excessive vessel formation, bone deterioration, and fibrocartilage calcification. Transgenic expression of active TGF-β1 in bone also induced enthesopathy with a phenotype similar to that observed in SMTS and DI mice. Systemic inhibition of TGF-β activity by injection of 1D11, a TGF-β-neutralizing antibody, but not a vehicle antibody, attenuated the excessive vessel formation and restored uncoupled bone remodeling in SMTS mice. 1D11-treated SMTS fibrocartilage had increased proteoglycan and decreased collagen X and matrix metalloproteinase 13 expression relative to control antibody treatment. Notably, inducible knockout of the TGF-β type II receptor in mouse MSCs preserved the bone microarchitecture and fibrocartilage composition after SMTS relative to the WT littermate controls. Thus, elevated levels of active TGF-β in the enthesis bone marrow induce the initial pathological changes of enthesopathy, indicating that TGF-β inhibition could be a potential therapeutic strategy.

Indexed as

AnimalsAntibodies, NeutralizingBone and BonesBone RemodelingCartilageCollagenDisease Models, AnimalEnthesopathyFibrocartilageMaleMesenchymal Stem CellsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicOsteoclastsAntibodies, NeutralizingCollagenReceptor, Transforming Growth Factor-beta Type IITgfbr2 protein, mouseTransforming Growth Factor betaBone BiologyBone disease

Identifiers

PMID29355842
PMCPMC5785263
OpenAlexW2784585580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.